Cornerstone Therapeutics, Inc.
Records under this name other than patents Cornerstone Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cornerstone Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,822,472 | Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof Formerly held Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 7,632,500 | Monoclonal antibodies against HMGB1 Formerly held Term ended Term ended Feb 5, 2025 · From the USPTO record | Term ended | Term ended Feb 5, 2025 | From the USPTO record |
| US 7,943,622 | Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof Formerly held Lapsed on the fee record Ended May 17, 2023 · High confidence | Lapsed on the fee record | Ended May 17, 2023 | High confidence |
| US 8,846,047 | Monoclonal antibodies against HMGB1 Formerly held Lapsed on the fee record Ended Sep 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | From the USPTO record |
| US 8,008,499 | Anabaseine derivatives, pharmaceutical compositions and methods of use thereof Formerly held Lapsed on the fee record Ended Aug 30, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2019 | From the USPTO record |
| US 8,003,684 | Crystal form and pharmaceutical compositions of (+)-R-zileuton Lapsed on the fee record Ended Aug 23, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 23, 2019 | From the USPTO record |
| US 7,662,965 | Anabaseine derivatives, pharmaceutical compositions and method of use thereof Formerly held Lapsed on the fee record Ended Feb 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2018 | From the USPTO record |
| US 7,470,521 | RAGE protein derivatives Formerly held Lapsed on the fee record Ended Dec 30, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2016 | From the USPTO record |
| US 8,129,130 | High Affinity Antibodies Against HMGB1 and Methods of Use Thereof Formerly held Lapsed on the fee record Ended Mar 6, 2016 · Medium confidence | Lapsed on the fee record | Ended Mar 6, 2016 | Medium confidence |
| US 7,288,250 | Monoclonal antibodies against HMGB1 Formerly held Lapsed on the fee record Ended Oct 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2015 | From the USPTO record |